<scp>GDF</scp> ‐15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes
GDF-15 is a promising biomarker in cirrhosis that reflects disease-driving pathomechanisms and independently predicts decompensation and mortality.
Authors
- Mattias Mandorfer (ORCID: https://orcid.org/0000-0003-2330-0017)
- Ksenia Brusilovskaya (ORCID: https://orcid.org/0000-0002-8234-5875)
- Benjamin Bödendorfer
- Paul Thöne (ORCID: https://orcid.org/0009-0001-1618-476X)
- L Hartl
- Silvia Lee (ORCID: https://orcid.org/0000-0001-5405-9735)
- T. Perkmann
- B. Eichelberger
- Benedikt Silvester Hofer (ORCID: https://orcid.org/0000-0003-3403-3372)
- Mathias Jachs (ORCID: https://orcid.org/0000-0003-2871-4147)
- Lorenz Balcar (ORCID: https://orcid.org/0000-0002-6708-3061)
- Kerstin Zinober (ORCID: https://orcid.org/0009-0004-0451-1593)
- Christian Sebesta (ORCID: https://orcid.org/0009-0001-7504-8506)
- Thomas Reiberger
- Philipp Schwabl
- Borka Radovanovic‐Petrova
- Georg Kramer
- Marlene Hintersteininger
- Benedikt Simbrunner
- Rubén Francés
- Simon Panzer
Institutions
- Universitat de Miguel Hernández d'Elx (ES)
- Austrian Academy of Sciences (AT)
- Instituto de Salud Carlos III (ES)
- CeMM Research Center for Molecular Medicine (AT)
- Landesklinikum Korneuburg (AT)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Karl Landsteiner University of Health Sciences (AT)
- Karl Landsteiner Society (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Liver International
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1111/liv.70516
- Citations
- 2
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 93.60